Utilizing advanced technology to tackle efficient biopharmaceutical design.

Schrödinger, Inc. will participate in the 3rd Annual Meeting of the Japanese Society for Antibody Research. Venue: Sendai International Center (Miyagi) 【Luncheon Seminar】 Date and Time: December 11 (Wed) 12:30 - 13:30 Title: Schrödinger's approach to physics-based antibody analysis and design Presenter: Shuu Ichihara (Schrödinger, Inc.) 【Booth No. 26】 We will introduce Schrödinger's drug discovery support platform and contract analysis services. - Latest docking simulation analysis - High-speed and high-precision binding free energy predictions - Multifunctional ligand-based analysis - Analysis using machine learning - Antibody structure modeling - Protein-protein interaction analysis - Discussion platform for managing, sharing, and analyzing simulation data and experimental data of compounds - Contract analysis services for each simulation

Schrödinger's drug discovery platform utilizes computational chemistry techniques based on the first principles of physics, enabling advanced drug design based on protein structural information. Its software is utilized by major pharmaceutical companies around the world. 【Symposium】 Date: June 11 (Tuesday) 9:15-11:45 Our Yuqi (Gary) Zhang will be one of the speakers at "Trends in Protein Science Aiming to Solve Pandemic Challenges." 【Luncheon Seminar】 Date: June 12 (Wednesday) 11:50 - 12:40 "Cutting-edge Antibody Engineering Based on Structure: The Interplay of Epitope Mapping, Cryo-EM, and in silico Techniques" Our Shuu Ichihara will be presenting. 【Poster Presentation】 Date: June 13 (Thursday) 13:30 - 14:30 "Structural Prediction of Antigen-Antibody Complexes Using Experimental Epitope Mapping and Low-Resolution CryoEM Data" Shuu Ichihara will present.